This paper aimed to derive analytical solutions for the shrinkage stress and cuspal deflection in model Class-II mesial-occlusal-distal (MOD) resin-composite restorations to better understand their dependence on geometrical and material parameters. Based on the stress solutions, it was shown how design curves could be obtained to guide the selection of dimensions and materials for the preparation and restoration of this class of cavities. The cavity wall was considered as a cantilevered beam while the resin composite was modeled as Winkler's elastic foundation with closely-spaced linear springs. Further, a mathematical model that took into account the combined effect of material properties, sample geometry and compliance of the surrounding constraint was employed to relate the shrinkage stress at the "tooth-composite" interface to the local compliance of the cavity wall. Exact analytical solutions were obtained for cuspal deflection and shrinkage stress along the cavity wall by solving the resulting diffesed by polymerization shrinkage. The study objective was to evaluate the midterm outcomes of transventricular mitral valve repair and its association with the initial anatomy of the mitral valve. This nonrandomized observational study included 88 patients (mean age, 60years; 69% were men) who underwent transventricular mitral valve repair for severe degenerative mitral regurgitation between 2011 and 2017. Mitral valve function was assessed by echocardiography at 1 and 6months and annually after the procedure. According to the location of mitral valve pathology, all patients were stratified into 4 anatomic types (A, B, C, and D). Results were assessed using Kaplan-Meier method, mixed-effects continuation ratio model, and multivariable Cox regression. Median follow-up of 42months (interquartile range, 27-55) was complete for 83 patients (94.3%). There were 3 late deaths 2 cardiac and 1 noncardiac. Recurrent mitral regurgitation greater than 2+ was observed in 29 patients (33%), and 18 patients (20.5%) underwent repeat surgery. Device suc only 82% at 3 years. Higher risk of mitral regurgitation recurrence occurred with complex degenerative pathology. Aortic valve reconstruction (AVRec) with neocuspidization or the Ozaki procedure with complete cusp replacement for aortic valve disease has excellent mid-term results in adults. Limited results of AVRec in pediatric patients have been reported. We report our early outcomes of the Ozaki procedure for congenital aortic and truncal valve disease. A retrospective analysis was performed on all 57 patients with congenital aortic and truncal valve disease who had a 3-leaflet Ozaki procedure at a single institution from August 2015 to February 2019. Outcome measures included mortality, surgical or catheter-based reinterventions, and echocardiographic measurements. Twenty-four patients had aortic regurgitation (AR), 6 had aortic stenosis (AS), and 27 patients had AS/AR. https://www.selleckchem.com/products/ms8709.html Two patients had quadricuspid valves, 26 had tricuspid, 20 had bicuspid, and 9 had unicusp aortic valves. Four patients had truncus arteriosus. Thirty-four patients had previous aortic valve repairs and 5 had replacements. Preoperative echocardilve function and continued annular growth. The AVRec procedure has acceptable short-term results and should be considered for valve reconstruction in pediatric patients with congenital aortic and truncal valve disease. Longer-term follow-up is necessary to determine the optimal patch material and late valve function and continued annular growth. Necroptosis plays an important role in cell death during pulmonary ischemia-reperfusion injury (IRI). We hypothesized that therapy with necrosulfonamide (NSA), a mixed-lineage kinase domain-like protein inhibitor, would attenuate lung IRI. Rats were assigned at random into the sham operation group (n=6), vehicle group (n=8), or NSA group (n=8). In the NSA and vehicle groups, the animals were heparinized and underwent left thoracotomy, and the left hilum was clamped for 90minutes, followed by reperfusion for 120minutes. NSA (0.5mg/body) and a solvent were administered i.p. in the NSA group and the vehicle group, respectively. The sham group underwent 210minutes of perfusion without ischemia. After reperfusion, arterial blood gas analysis, physiologic data, lung wet-to-dry weight ratio, histologic changes, and cytokine levels were assessed. Fluorescence double immunostaining was performed to evaluate necroptosis and apoptosis. Arterial partial pressure of oxygen/fraction of inspired oxygen (PaO /FiO ) was better, dynamic compliance was higher, and mean airway pressure and lung edema were lower in the NSA group compared with the vehicle group. Moreover, in the NSA group, lung injury was significantly alleviated, and the mean number of necroptotic cells (55.3±4.06 vs 78.2±6.87; P=.024), but not of apoptotic cells (P=.084), was significantly reduced compared with the vehicle group. Interleukin (IL)-1β and IL-6 levels were significantly lower with NSA administration. In a rat model, our results suggest that NSA may have a potential protective role in lung IRI through the inhibition of necroptosis. In a rat model, our results suggest that NSA may have a potential protective role in lung IRI through the inhibition of necroptosis. We investigated the impact of additional antegrade pulmonary blood flow on the long-term outcomes after bidirectional Glenn shunt. From 2001 to 2015, 279 patients underwent bidirectional Glenn shunt as an interim palliation for a functionally single ventricle. After excluding patients with a previous Kawashima or Norwood operation, 202 patients with preexisting antegrade pulmonary blood flow before bidirectional Glenn shunt were included in this study. Antegrade pulmonary blood flow was eliminated in 110 patients (no antegrade pulmonary blood flow group) and maintained in 92 patients (antegrade pulmonary blood flow group). The impact of antegrade pulmonary blood flow at bidirectional Glenn shunt on long-term outcome was analyzed using inverse probability of treatment weighting. Median age and body weight at bidirectional Glenn shunt were 8months and 7.8kg, respectively. Prolonged chest tube drainage or readmission for effusion after bidirectional Glenn shunt was more frequent in the antegrade pulmonary blood flow group (odds ratio, 3.